<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04313920</url>
  </required_header>
  <id_info>
    <org_study_id>BL48</org_study_id>
    <nct_id>NCT04313920</nct_id>
  </id_info>
  <brief_title>Study of a Carbohydrate Drink in Adults</brief_title>
  <official_title>Postprandial Gastric Emptying and Glycemic Response to a Pre-Operative Carbohydrate Drink in Adults With Pre-diabetes and Type II Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the postprandial glycemic response and rates of
      gastric emptying in healthy subjects and those with pre-diabetes and type 2 diabetes
      following oral ingestion of carbohydrate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 7, 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Glucose Concentration</measure>
    <time_frame>Baseline 0 to 240 Minutes</time_frame>
    <description>Area under the curve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin Concentration</measure>
    <time_frame>Baseline 0 to 240 Minutes</time_frame>
    <description>Area under the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional Product Assessment</measure>
    <time_frame>Immediately following product consumption</time_frame>
    <description>Subject completed questionnaire with 2 product liking questions using 7-9 point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Appetitive Ratings</measure>
    <time_frame>Baseline 0 to 240 Minutes</time_frame>
    <description>Subject completed 4 visual analog scale statements scaled from Not at All to Extremely</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastric Emptying</measure>
    <time_frame>Baseline 0 to 180 Minutes</time_frame>
    <description>Rate of gastric emptying</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Glycemic Response</condition>
  <arm_group>
    <arm_group_label>Nutritional Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ready to drink liquid</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Supplement</intervention_name>
    <description>50 g Carbohydrate</description>
    <arm_group_label>Nutritional Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has voluntarily signed and dated an informed consent form and provided Health
             Insurance Portability and Accountability Act (HIPAA) authorization

          -  Subject is healthy or has pre-diabetes or type 2 diabetes

          -  Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum

          -  Subject's BMI is &gt; 18.5 kg/m2 and ≤ 40.0 kg/m2

          -  If subject is on a chronic medication, the dosage has been constant

          -  Subject states willingness to follow protocol

        Exclusion Criteria:

          -  Subject uses exogenous insulin or Glucagon-like peptide-1 (GLP-1) receptor agonists
             for glucose control

          -  Subject has type 1 diabetes

          -  Subject has a history of diabetic ketoacidosis

          -  Subject has current infection; has had in-patient surgery, or corticosteroid treatment
             or antibiotics

          -  Subject has an active malignancy

          -  Subject has had a significant cardiovascular event ≤ six months or history of
             congestive heart failure

          -  Subject has end-stage organ failure or is status post organ transplant.

          -  Subject has a history of renal disease

          -  Subject has current hepatic disease

          -  Subject has a history of severe gastroparesis

          -  Subject has a chronic, contagious, infectious disease

          -  Subject has taken/is currently taking any herbals, dietary supplements, or medications
             that could profoundly affect blood glucose

          -  Subject has clotting or bleeding disorders

          -  Subject is known to be allergic or intolerant to any ingredient found in the study
             products

          -  Subject is a participant in another study that has not been approved as a concomitant
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bridget Cassady, PhD, RDN, LD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Health Awareness, Inc.</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Biofortis</name>
      <address>
        <city>Addison</city>
        <state>Illinois</state>
        <zip>60101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Great Lakes Clinical Trials</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60640</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 11, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

